Glenn Steele Jr. Md. Phd.
Director, WellCare.
Companies
- PTC TherapeuticsBoard member Jun 11, 2015 to now1
- WellCareBoard member Nov 3, 2009 to May 24, 20182
- Weis MarketsBoard member Nov 2, 2009 to Nov 2, 20093
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
PTC Therapeutics PTCT22,500 shares4$1.4M at $61.38Jan 2, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jan 2, 2026Granted 4,000 shares of PTC Therapeutics4
- Jan 2, 2026Sold 12,000 shares at $76.35 of PTC Therapeutics4
- Jan 2, 2026Exercised options 12,000 shares at $30.86 of PTC Therapeutics4
- Jan 3, 2025Granted 4,000 shares of PTC Therapeutics5
- Feb 15, 2024Granted 4,000 shares of PTC Therapeutics6
- Jan 5, 2023Granted 4,000 shares of PTC Therapeutics7
- Jan 7, 2022Granted 3,200 shares of PTC Therapeutics8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPTC Therapeutics, Board member
- 2SEC EDGARWellCare, Board member
- 3SEC EDGARWeis Markets, Board member
- 4
- 5SEC EDGARForm 4 filed Jan 7, 2025
- 6SEC EDGARForm 4 filed Feb 16, 2024
- 7SEC EDGARForm 4 filed Jan 9, 2023
- 8SEC EDGARForm 4 filed Jan 11, 2022